Skip to main content
Top
Published in: Acta Neurochirurgica 8/2019

01-08-2019 | Meningioma | Original Article - Tumor - Meningioma

Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas

Authors: Eileen Maria Susanne Streckert, Katharina Hess, Peter B. Sporns, Alborz Adeli, Caroline Brokinkel, Jan Kriz, Markus Holling, Hans Theodor Eich, Werner Paulus, Dorothee Cäcilia Spille, Albertus T. C. J. van Eck, David R. Raleigh, Michael W. McDermott, Walter Stummer, Benjamin Brokinkel

Published in: Acta Neurochirurgica | Issue 8/2019

Login to get access

Abstract

Background

Despite considerable rates of recurrence and mortality in atypical meningiomas, reliable predictors for estimating postoperative long-term prognosis remain elusive.

Methods

Clinical, histopathological, and radiological variables from 138 patients, including 64 females and 74 males (46% and 54%, median age 62 years), who underwent surgery for intracranial atypical meningioma were retrospectively analyzed. Associations between variables and recurrence and mortality were investigated using uni- and multivariate analyses.

Results

Gross total (GTR) and subtotal resection (STR) was achieved in 81% and 19% of cases, respectively. Within a median follow-up of 62 months, recurrence occurred in 52 (38%) and mortality in 22 (16%) cases. In patients who did not receive adjuvant irradiation, recurrence rates were higher after STR than after GTR (32% vs 63%, p = 0.025). In univariate analyses, only intratumoral calcifications on preoperative MRI (p = 0.012) and the presence of brain invasion in the absence of other histological grading criteria (p = 0.010) were correlated with longer progression-free intervals (PFI). In multivariate analyses, patient age was positively (HR 1.03, 95%CI 1.04–1.05; p = 0.018) and the presence of brain invasion as the only grading criterion (HR 0.37, 95%CI 0.19–0.74; p = 0.005) was negatively related with progression, while rising age at the time of surgery (HR 1.07, 95%CI 1.03–1.12; p = 0.001) was prognostic for mortality.

Conclusions

PFI was longer in brain invasive but otherwise histological benign meningiomas and in tumors displaying calcifications on preoperative MRI. Advancing patient age and lower Karnofsky Performance Score were associated with higher overall mortality.
Literature
1.
go back to reference Adeli A, Hess K, Mawrin C, Streckert EMS, Stummer W, Paulus W, Kemmling A, Holling M, Heindel W, Schmidt R, Spille DC, Sporns PB, Brokinkel B (2018) Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging. Oncotarget 9:35974–35982CrossRefPubMedPubMedCentral Adeli A, Hess K, Mawrin C, Streckert EMS, Stummer W, Paulus W, Kemmling A, Holling M, Heindel W, Schmidt R, Spille DC, Sporns PB, Brokinkel B (2018) Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging. Oncotarget 9:35974–35982CrossRefPubMedPubMedCentral
2.
go back to reference Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG II (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 discussion 60 CrossRefPubMed Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG II (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 discussion 60 CrossRefPubMed
3.
go back to reference Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-Oncology 16:1547–1553CrossRefPubMedPubMedCentral Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-Oncology 16:1547–1553CrossRefPubMedPubMedCentral
5.
go back to reference Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro-Oncology 19:1298–1307CrossRefPubMedPubMedCentral Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro-Oncology 19:1298–1307CrossRefPubMedPubMedCentral
6.
go back to reference Brokinkel B, Holling M, Spille DC, Hess K, Sauerland C, Bleimuller C, Paulus W, Wolfer J, Stummer W (2017) Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients. J Neurosurg 126:1201–1211CrossRefPubMed Brokinkel B, Holling M, Spille DC, Hess K, Sauerland C, Bleimuller C, Paulus W, Wolfer J, Stummer W (2017) Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients. J Neurosurg 126:1201–1211CrossRefPubMed
7.
go back to reference Brokinkel B, Stummer W, Sporns P (2018) Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression? J Neuro-Oncol 137(1):219–221CrossRef Brokinkel B, Stummer W, Sporns P (2018) Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression? J Neuro-Oncol 137(1):219–221CrossRef
8.
go back to reference Budohoski KP, Clerkin J, Millward CP, O’Halloran PJ, Waqar M, Looby S, Young AMH, Guilfoyle MR, Fitzroll D, Devadass A, Allinson K, Farrell M, Javadpour M, Jenkinson MD, Santarius T, Kirollos RW (2018) Predictors of early progression of surgically treated atypical meningiomas. Acta Neurochir 160:1813–1822CrossRefPubMed Budohoski KP, Clerkin J, Millward CP, O’Halloran PJ, Waqar M, Looby S, Young AMH, Guilfoyle MR, Fitzroll D, Devadass A, Allinson K, Farrell M, Javadpour M, Jenkinson MD, Santarius T, Kirollos RW (2018) Predictors of early progression of surgically treated atypical meningiomas. Acta Neurochir 160:1813–1822CrossRefPubMed
9.
go back to reference Champeaux C, Dunn L (2016) World Health Organization grade II meningioma: a 10-year retrospective study for recurrence and prognostic factor assessment. World Neurosurg 89:180–186CrossRefPubMed Champeaux C, Dunn L (2016) World Health Organization grade II meningioma: a 10-year retrospective study for recurrence and prognostic factor assessment. World Neurosurg 89:180–186CrossRefPubMed
10.
go back to reference Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neuro-Oncol 129:337–345CrossRef Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neuro-Oncol 129:337–345CrossRef
11.
go back to reference Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR (2018) Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg. https://doi.org/10.3171/2017.9.JNS171609 Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR (2018) Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg. https://​doi.​org/​10.​3171/​2017.​9.​JNS171609
12.
go back to reference Endo T, Narisawa A, Ali HS, Murakami K, Watanabe T, Watanabe M, Jokura H, Endo H, Fujimura M, Sonoda Y, Tominaga T (2016) A study of prognostic factors in 45 cases of atypical meningioma. Acta Neurochir 158:1661–1667CrossRefPubMed Endo T, Narisawa A, Ali HS, Murakami K, Watanabe T, Watanabe M, Jokura H, Endo H, Fujimura M, Sonoda Y, Tominaga T (2016) A study of prognostic factors in 45 cases of atypical meningioma. Acta Neurochir 158:1661–1667CrossRefPubMed
13.
go back to reference Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391CrossRefPubMed Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391CrossRefPubMed
14.
go back to reference Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184–189CrossRefPubMed Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184–189CrossRefPubMed
15.
go back to reference Hammouche S, Clark S, Wong AH, Eldridge P, Farah JO (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir 156:1475–1481CrossRefPubMed Hammouche S, Clark S, Wong AH, Eldridge P, Farah JO (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir 156:1475–1481CrossRefPubMed
16.
go back to reference Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A, Lo SS, Ishkanian F, Komotar RJ (2015) The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83:808–815CrossRefPubMed Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A, Lo SS, Ishkanian F, Komotar RJ (2015) The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83:808–815CrossRefPubMed
18.
go back to reference Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougere C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF, International Consortium on M (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro-Oncology 21:i44–i61CrossRefPubMedPubMedCentral Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougere C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF, International Consortium on M (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro-Oncology 21:i44–i61CrossRefPubMedPubMedCentral
19.
go back to reference Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, Bulbeck H, Das K, Farrell M, Looby S, Hickey H, Preusser M, Mallucci CL, Hughes D, Gamble C, Weber DC (2015) The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials 16:519CrossRefPubMedPubMedCentral Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, Bulbeck H, Das K, Farrell M, Looby S, Hickey H, Preusser M, Mallucci CL, Hughes D, Gamble C, Weber DC (2015) The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials 16:519CrossRefPubMedPubMedCentral
20.
go back to reference Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, Wu P, Golfinos JG, Reuss D, Neidert MC, Wirsching HG, Baumgarten P, Herold-Mende C, Wick W, Harter PN, Weller M, von Deimling A, Snuderl M, Sen C, Sahm F (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955–963CrossRefPubMed Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, Wu P, Golfinos JG, Reuss D, Neidert MC, Wirsching HG, Baumgarten P, Herold-Mende C, Wick W, Harter PN, Weller M, von Deimling A, Snuderl M, Sen C, Sahm F (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955–963CrossRefPubMed
21.
go back to reference Kawahara Y, Nakada M, Hayashi Y, Kai Y, Hayashi Y, Uchiyama N, Nakamura H, Kuratsu J, Hamada J (2012) Prediction of high-grade meningioma by preoperative MRI assessment. J Neuro-Oncol 108:147–152CrossRef Kawahara Y, Nakada M, Hayashi Y, Kai Y, Hayashi Y, Uchiyama N, Nakamura H, Kuratsu J, Hamada J (2012) Prediction of high-grade meningioma by preoperative MRI assessment. J Neuro-Oncol 108:147–152CrossRef
22.
go back to reference Klinger DR, Flores BC, Lewis JJ, Hatanpaa K, Choe K, Mickey B, Barnett S (2015) Atypical meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 84:839–845CrossRefPubMed Klinger DR, Flores BC, Lewis JJ, Hatanpaa K, Choe K, Mickey B, Barnett S (2015) Atypical meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 84:839–845CrossRefPubMed
23.
go back to reference Li H, Zhang YS, Zhang GB, Zhang GJ, Wang B, Li D, Wu Z, Zhang JT (2019) Treatment protocol, long-term follow-up, and predictors of mortality in 302 cases of atypical meningioma. World Neurosurg 122:e1275–e1284CrossRefPubMed Li H, Zhang YS, Zhang GB, Zhang GJ, Wang B, Li D, Wu Z, Zhang JT (2019) Treatment protocol, long-term follow-up, and predictors of mortality in 302 cases of atypical meningioma. World Neurosurg 122:e1275–e1284CrossRefPubMed
24.
go back to reference Li H, Zhao M, Jiao Y, Ge P, Li Z, Ma J, Wang S, Cao Y, Zhao J (2016) Prediction of high-grade pediatric meningiomas: magnetic resonance imaging features based on T1-weighted, T2-weighted, and contrast-enhanced T1-weighted images. World Neurosurg 91:89–95CrossRefPubMed Li H, Zhao M, Jiao Y, Ge P, Li Z, Ma J, Wang S, Cao Y, Zhao J (2016) Prediction of high-grade pediatric meningiomas: magnetic resonance imaging features based on T1-weighted, T2-weighted, and contrast-enhanced T1-weighted images. World Neurosurg 91:89–95CrossRefPubMed
25.
go back to reference Lin BJ, Chou KN, Kao HW, Lin C, Tsai WC, Feng SW, Lee MS, Hueng DY (2014) Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg 121:1201–1208CrossRefPubMed Lin BJ, Chou KN, Kao HW, Lin C, Tsai WC, Feng SW, Lee MS, Hueng DY (2014) Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg 121:1201–1208CrossRefPubMed
26.
go back to reference Liu Y, Chotai S, Chen M, Jin S, Qi ST, Pan J (2015) Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior. PLoS One 10:e0118908CrossRefPubMedPubMedCentral Liu Y, Chotai S, Chen M, Jin S, Qi ST, Pan J (2015) Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior. PLoS One 10:e0118908CrossRefPubMedPubMedCentral
27.
go back to reference Masalha W, Heiland DH, Franco P, Delev D, Haaker JG, Schnell O, Scheiwe C, Grauvogel J (2018) Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J Neuro-Oncol 136:147–154CrossRef Masalha W, Heiland DH, Franco P, Delev D, Haaker JG, Schnell O, Scheiwe C, Grauvogel J (2018) Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J Neuro-Oncol 136:147–154CrossRef
28.
go back to reference Nanda A, Bir SC, Konar S, Maiti T, Kalakoti P, Jacobsohn JA, Guthikonda B (2016) Outcome of resection of WHO grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosci 31:112–121CrossRefPubMed Nanda A, Bir SC, Konar S, Maiti T, Kalakoti P, Jacobsohn JA, Guthikonda B (2016) Outcome of resection of WHO grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosci 31:112–121CrossRefPubMed
30.
go back to reference Perry A, Louis DN, von Deimling A, Sahm F, Rushing EJ, Mawrin C, Claus EB, Loeffler J, Sadetzki S (2016) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimlig A (eds) WHO classification of tumors of the central nervous system. International Agency on Cancer Research, Lyon, pp 232–245 Perry A, Louis DN, von Deimling A, Sahm F, Rushing EJ, Mawrin C, Claus EB, Loeffler J, Sadetzki S (2016) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimlig A (eds) WHO classification of tumors of the central nervous system. International Agency on Cancer Research, Lyon, pp 232–245
31.
go back to reference Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M (2018) De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Neuro-Oncology 20:1113–1121CrossRefPubMed Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M (2018) De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Neuro-Oncology 20:1113–1121CrossRefPubMed
32.
go back to reference Phonwijit L, Khawprapa C, Sitthinamsuwan B (2017) Progression-free survival and factors associated with postoperative recurrence in 126 patients with atypical intracranial meningioma. World Neurosurg 107:698–705CrossRefPubMed Phonwijit L, Khawprapa C, Sitthinamsuwan B (2017) Progression-free survival and factors associated with postoperative recurrence in 126 patients with atypical intracranial meningioma. World Neurosurg 107:698–705CrossRefPubMed
34.
go back to reference Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP (2018) Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg 129:35–47CrossRefPubMed Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP (2018) Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg 129:35–47CrossRefPubMed
35.
go back to reference Rydzewski NR, Lesniak MS, Chandler JP, Kalapurakal JA, Pollom E, Tate MC, Bloch O, Kruser T, Dalal P, Sachdev S (2018) Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer 124:734–742CrossRefPubMed Rydzewski NR, Lesniak MS, Chandler JP, Kalapurakal JA, Pollom E, Tate MC, Bloch O, Kruser T, Dalal P, Sachdev S (2018) Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer 124:734–742CrossRefPubMed
36.
go back to reference Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC (2018) Prognostic factors for progression in atypical meningioma. J Neurosurg 129:1240–1248CrossRefPubMed Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC (2018) Prognostic factors for progression in atypical meningioma. J Neurosurg 129:1240–1248CrossRefPubMed
37.
go back to reference Sicking J, Voss KM, Spille DC, Schipmann S, Holling M, Paulus W, Hess K, Steinbicker AU, Stummer W, Grauer O, Wolfer J, Brokinkel B (2018) The evolution of cranial meningioma surgery-a single-center 25-year experience. Acta Neurochir 160:1801–1812CrossRefPubMed Sicking J, Voss KM, Spille DC, Schipmann S, Holling M, Paulus W, Hess K, Steinbicker AU, Stummer W, Grauer O, Wolfer J, Brokinkel B (2018) The evolution of cranial meningioma surgery-a single-center 25-year experience. Acta Neurochir 160:1801–1812CrossRefPubMed
39.
go back to reference Spille DC, Hess K, Sauerland C, Sanai N, Stummer W, Paulus W, Brokinkel B (2016) Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 93:346–354CrossRefPubMed Spille DC, Hess K, Sauerland C, Sanai N, Stummer W, Paulus W, Brokinkel B (2016) Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 93:346–354CrossRefPubMed
40.
go back to reference Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347–354 discussion 354-345; quiz 355 CrossRefPubMed Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347–354 discussion 354-345; quiz 355 CrossRefPubMed
41.
go back to reference Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ (2017) Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro-Oncology 19:1263–1270CrossRefPubMedPubMedCentral Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ (2017) Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro-Oncology 19:1263–1270CrossRefPubMedPubMedCentral
42.
go back to reference Yoon H, Mehta MP, Perumal K, Helenowski IB, Chappell RJ, Akture E, Lin Y, Marymont MA, Sejpal S, Parsa A, Chandler JR, Bendok BR, Rosenow J, Salamat S, Kumthekar P, Raizer JK, Baskaya MK (2015) Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. J Cancer Res Ther 11:59–66PubMed Yoon H, Mehta MP, Perumal K, Helenowski IB, Chappell RJ, Akture E, Lin Y, Marymont MA, Sejpal S, Parsa A, Chandler JR, Bendok BR, Rosenow J, Salamat S, Kumthekar P, Raizer JK, Baskaya MK (2015) Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. J Cancer Res Ther 11:59–66PubMed
43.
go back to reference Zhi M, Girvigian MR, Miller MJ, Chen JC, Schumacher AJ, Rahimian J, Lodin K (2019) Long-term outcomes of newly diagnosed resected atypical meningiomas and the role of adjuvant radiotherapy. World Neurosurg 122:e1153–e1161CrossRefPubMed Zhi M, Girvigian MR, Miller MJ, Chen JC, Schumacher AJ, Rahimian J, Lodin K (2019) Long-term outcomes of newly diagnosed resected atypical meningiomas and the role of adjuvant radiotherapy. World Neurosurg 122:e1153–e1161CrossRefPubMed
Metadata
Title
Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas
Authors
Eileen Maria Susanne Streckert
Katharina Hess
Peter B. Sporns
Alborz Adeli
Caroline Brokinkel
Jan Kriz
Markus Holling
Hans Theodor Eich
Werner Paulus
Dorothee Cäcilia Spille
Albertus T. C. J. van Eck
David R. Raleigh
Michael W. McDermott
Walter Stummer
Benjamin Brokinkel
Publication date
01-08-2019
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 8/2019
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-019-03956-8

Other articles of this Issue 8/2019

Acta Neurochirurgica 8/2019 Go to the issue